| Literature DB >> 31309884 |
Aida Raigon-Ponferrada1,2,3, María E D Recio1,4, Jose L Guerrero-Orriach1,2,3,5, Alfredo Malo-Manso1,2, Juan J Escalona-Belmonte1,2, Marta R Aliaga1,2, Alicia R Fernández1,2, Francisco J F García1,6, Emilio A Conejo4, José Cruz-Mañas1,2.
Abstract
Breast cancer is a complex heterogeneous disease that is categorized into several histological and genomic subtypes with relevant prognostic and therapeutical implications. Such diversity requires a multidisciplinary approach for a comprehensive treatment that will involve surgeons, radiotherapists and medical oncologists. Breast cancer is classified as either local (or locoregional), which stands for 90-95% of cases, or metastatic, representing 5% of cases. The management of breast cancer will be determined by the stage of the disease. The treatment of local breast cancer is based on surgery and/or radiotherapy. Systemic breast cancer requires chemotherapy and/or endocrine and/or biological therapy. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.Entities:
Keywords: Anesthetic drugs and techniques; breast cancer; cancer recurrence; immune cells; natural killerzzm321990cells; opioids; propofol; volatile agent.
Mesh：
Year: 2019 PMID： 31309884 DOI： 10.2174/1381612825666190712183436
Source DB: PubMed Journal: Curr Pharm Des ISSN： 1381-6128 Impact factor: 3.116